A detailed history of British Columbia Investment Management Corp transactions in Boston Scientific Corp stock. As of the latest transaction made, British Columbia Investment Management Corp holds 564,188 shares of BSX stock, worth $47 Million. This represents 0.27% of its overall portfolio holdings.

Number of Shares
564,188
Previous 1,248,074 54.8%
Holding current value
$47 Million
Previous $85.5 Million 49.17%
% of portfolio
0.27%
Previous 0.6%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$67.33 - $77.71 $46 Million - $53.1 Million
-683,886 Reduced 54.8%
564,188 $43.4 Million
Q1 2024

May 14, 2024

SELL
$57.6 - $68.62 $65.6 Million - $78.2 Million
-1,139,060 Reduced 47.72%
1,248,074 $85.5 Million
Q4 2023

Feb 14, 2024

BUY
$48.64 - $57.81 $2.01 Million - $2.38 Million
41,234 Added 1.76%
2,387,134 $138 Million
Q3 2023

Nov 14, 2023

BUY
$50.19 - $54.68 $31.6 Million - $34.4 Million
629,108 Added 36.64%
2,345,900 $124 Million
Q2 2023

Aug 11, 2023

BUY
$49.72 - $54.64 $79 Million - $86.8 Million
1,588,697 Added 1240.25%
1,716,792 $92.9 Million
Q1 2023

May 12, 2023

BUY
$45.09 - $50.03 $57,760 - $64,088
1,281 Added 1.01%
128,095 $6.41 Million
Q4 2022

Feb 10, 2023

SELL
$39.56 - $47.22 $578,723 - $690,781
-14,629 Reduced 10.34%
126,814 $5.87 Million
Q3 2022

Nov 10, 2022

SELL
$36.71 - $109.66 $880,709 - $2.63 Million
-23,991 Reduced 14.5%
141,443 $5.48 Million
Q2 2022

Aug 12, 2022

SELL
$35.24 - $47.1 $1.92 Million - $2.57 Million
-54,558 Reduced 24.8%
165,434 $6.17 Million
Q1 2022

May 12, 2022

SELL
$40.9 - $45.1 $1.24 Million - $1.36 Million
-30,211 Reduced 12.07%
219,992 $9.74 Million
Q4 2021

Feb 11, 2022

SELL
$38.07 - $44.87 $480,443 - $566,259
-12,620 Reduced 4.8%
250,203 $10.6 Million
Q3 2021

Nov 12, 2021

BUY
$41.23 - $45.88 $24,160 - $26,885
586 Added 0.22%
262,823 $11.4 Million
Q2 2021

Aug 09, 2021

SELL
$38.58 - $44.24 $4.92 Million - $5.64 Million
-127,591 Reduced 32.73%
262,237 $11.2 Million
Q1 2021

Apr 30, 2021

SELL
$35.27 - $39.67 $272,354 - $306,331
-7,722 Reduced 1.94%
389,828 $15.1 Million
Q4 2020

Feb 02, 2021

SELL
$33.15 - $41.97 $175,595 - $222,315
-5,297 Reduced 1.31%
397,550 $14.3 Million
Q3 2020

Nov 10, 2020

BUY
$34.44 - $42.23 $828,282 - $1.02 Million
24,050 Added 6.35%
402,847 $15.4 Million
Q2 2020

Aug 12, 2020

BUY
$30.19 - $39.11 $6.83 Million - $8.85 Million
226,166 Added 148.18%
378,797 $13.3 Million
Q1 2020

May 13, 2020

SELL
$25.83 - $45.71 $4.55 Million - $8.05 Million
-176,075 Reduced 53.57%
152,631 $4.98 Million
Q4 2019

Feb 12, 2020

BUY
$37.87 - $45.37 $5.21 Million - $6.25 Million
137,664 Added 72.06%
328,706 $14.9 Million
Q3 2019

Nov 14, 2019

SELL
$40.31 - $43.45 $3.22 Million - $3.47 Million
-79,916 Reduced 29.49%
191,042 $7.77 Million
Q2 2019

Aug 12, 2019

BUY
$34.91 - $42.98 $417,663 - $514,212
11,964 Added 4.62%
270,958 $11.6 Million
Q1 2019

May 08, 2019

SELL
$32.91 - $40.75 $4.27 Million - $5.29 Million
-129,801 Reduced 33.39%
258,994 $9.94 Million
Q4 2018

Feb 13, 2019

BUY
$31.73 - $39.04 $263,771 - $324,539
8,313 Added 2.18%
388,795 $13.7 Million
Q3 2018

Nov 13, 2018

SELL
$32.83 - $38.63 $2.1 Million - $2.47 Million
-64,018 Reduced 14.4%
380,482 $14.6 Million
Q2 2018

Aug 09, 2018

SELL
$26.84 - $34.32 $1.94 Million - $2.48 Million
-72,125 Reduced 13.96%
444,500 $14.5 Million
Q1 2018

May 15, 2018

SELL
$25.2 - $28.54 $10.6 Million - $12 Million
-420,902 Reduced 44.89%
516,625 $14.1 Million
Q4 2017

Feb 20, 2018

BUY
$24.79 - $29.8 $8.84 Million - $10.6 Million
356,701 Added 61.41%
937,527 $23.2 Million
Q3 2017

Nov 14, 2017

BUY
$26.26 - $29.17 $15.3 Million - $16.9 Million
580,826
580,826 $16.9 Million

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $119B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track British Columbia Investment Management Corp Portfolio

Follow British Columbia Investment Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of British Columbia Investment Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on British Columbia Investment Management Corp with notifications on news.